Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
AN2 Therapeutics, Inc. (ANTX) had Return on Equity of -66.29% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-35.17M |
|
-- |
|
-- |
|
$38.11M |
|
$-38.11M |
|
$2.94M |
|
$-35.17M |
|
$-35.17M |
|
$-35.17M |
|
$-35.17M |
|
$-35.17M |
|
$-35.17M |
|
$-38.11M |
|
$-39.18M |
|
30.22M |
|
30.22M |
|
$-1.16 |
|
$-1.16 |
|
| Balance Sheet Financials | |
$59.94M |
|
-- |
|
$2.01M |
|
$61.95M |
|
$8.72M |
|
-- |
|
$0.17M |
|
$8.89M |
|
$53.06M |
|
$53.06M |
|
$53.06M |
|
27.41M |
|
| Cash Flow Statement Financials | |
$-29.83M |
|
$28.31M |
|
$0.11M |
|
$21.35M |
|
$19.94M |
|
$-1.41M |
|
$6.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-66.29% |
-66.29% |
|
-56.78% |
|
-66.29% |
|
$1.94 |
|
$-0.99 |
|
$-0.99 |
|